Anti Hair Loss Product CB-03-01 17alpha-Propionate CAS 19608-29-8 CB-03-01 Raw Powder CB-03-01
Basic Info
Model NO. | Condavo-CB-03-01 |
Powder | Yes |
Customized | Customized |
Certification | GMP, HSE, ISO 9001, USP, BP |
Suitable for | Adult |
State | Solid |
Purity | >99% |
Name | CB-03-01 |
Product Name | CB-03-01 Powder |
Appearance | White Powder |
Color | White Color |
CAS | 19608-29-8 |
Einecs | 1533716-785-6 |
Mf | C24h34o5 |
Boiling Point | 538.898 C at 760 Mmhg |
Density | 1.193 |
Test Method | HPLC UV |
Grade | Pharmaceutical Grade |
Assay | 99% |
Shelf Life | 2 Years |
Function | Hair Loss Treatment |
COA | Available |
Transport Package | 1kg/ Aluminium Bag or 25kg/Drum; as Required |
Specification | 99% |
Trademark | Condavo |
Origin | Shaanxi |
Production Capacity | 2000kg/Month |
Product Description
Anti Hair Loss Product CB-03-01 17alpha-Propionate CAS 19608-29-8 CB-03-01 Raw Powder CB-03-01Product Description
Product Name | CB-03-01 |
Appearance | White to off-White Powder |
Assay | 99%min, 98.0% --102.0% |
Test | HPLC,UV |
CAS | 19608-29-8 |
MF | C24h34o5 |
Storage Temperature | Cool Dry Place |
CB-03-01 is a molecule that acts at the level of the skin. The molecule has a unique mechanism that acts at the skin surface, and is quickly metabolized to free inactive cortexolone, a substance naturally found in the body. The molecule has been evaluated in a variety of animal models as well as initial human trials in Europe. The results of these studies demonstrate that CB-03-01 appears to have potent activity without significant local or systemic side effects.
Sample Display
Function & Application
CB-03-01 is the drug for the treatment of hair loss dwindled. It has same function and application with RU58841 and Setipiprant.CB-03-01 is a molecule that acts at the level of the skin, blocking dihydrotestosterone (DHT) from binding to the receptor in the cell. The molecule has a unique mechanism that acts at the skin surface, and is quickly metabolized to free inactive cortexolone, a substance naturally found in the body. The molecule has been evaluated in a variety of animal models as well as initial human trials in Europe. The results of these studies demonstrate that CB-03-01 appears to have potent activity without significant local or systemic side effects.CB-03-01 is the drug for the treatment of hair loss dwindled.It has same function and application with RU58841 and Setipiprant.
Specification
Packaging & Shipping
Certifications
Our Team
About Us